Cargando…

Epitope Coverage of Anti-SARS-CoV-2 Nucleocapsid IgA and IgG Antibodies Correlates with Protection against Re-Infection by New Variants in Subsequent Waves of the COVID-19 Pandemic

The COVID-19 pandemic continues to affect individuals across the globe, with some individuals experiencing more severe disease than others. The relatively high frequency of re-infections and breakthrough infections observed with SARS-CoV-2 highlights the importance of extending our understanding of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mullins, Michelle O., Smith, Muneerah, Maboreke, Hazel, Nel, Andrew J. M., Ntusi, Ntobeko A. B., Burgers, Wendy A., Blackburn, Jonathan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967965/
https://www.ncbi.nlm.nih.gov/pubmed/36851798
http://dx.doi.org/10.3390/v15020584
_version_ 1784897396879130624
author Mullins, Michelle O.
Smith, Muneerah
Maboreke, Hazel
Nel, Andrew J. M.
Ntusi, Ntobeko A. B.
Burgers, Wendy A.
Blackburn, Jonathan M.
author_facet Mullins, Michelle O.
Smith, Muneerah
Maboreke, Hazel
Nel, Andrew J. M.
Ntusi, Ntobeko A. B.
Burgers, Wendy A.
Blackburn, Jonathan M.
author_sort Mullins, Michelle O.
collection PubMed
description The COVID-19 pandemic continues to affect individuals across the globe, with some individuals experiencing more severe disease than others. The relatively high frequency of re-infections and breakthrough infections observed with SARS-CoV-2 highlights the importance of extending our understanding of immunity to COVID-19. Here, we aim to shed light on the importance of antibody titres and epitope utilization in protection from re-infection. Health care workers are highly exposed to SARS-CoV-2 and are therefore also more likely to become re-infected. We utilized quantitative, multi-antigen, multi-epitope SARS-CoV-2 protein microarrays to measure IgG and IgA titres against various domains of the nucleocapsid and spike proteins. Potential re-infections in a large, diverse health care worker cohort (N = 300) during the second wave of the pandemic were identified by assessing the IgG anti-N titres before and after the second wave. We assessed epitope coverage and antibody titres between the ‘single infection’ and ‘re-infection’ groups. Clear differences were observed in the breadth of the anti-N response before the second wave, with the epitope coverage for both IgG (p = 0.019) and IgA (p = 0.015) being significantly increased in those who did not become re-infected compared to those who did. Additionally, the IgG anti-N (p = 0.004) and anti-S titres (p = 0.018) were significantly higher in those not re-infected. These results highlight the importance of the breadth of elicited antibody epitope coverage following natural infection in protection from re-infection and disease in the COVID-19 pandemic.
format Online
Article
Text
id pubmed-9967965
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99679652023-02-27 Epitope Coverage of Anti-SARS-CoV-2 Nucleocapsid IgA and IgG Antibodies Correlates with Protection against Re-Infection by New Variants in Subsequent Waves of the COVID-19 Pandemic Mullins, Michelle O. Smith, Muneerah Maboreke, Hazel Nel, Andrew J. M. Ntusi, Ntobeko A. B. Burgers, Wendy A. Blackburn, Jonathan M. Viruses Brief Report The COVID-19 pandemic continues to affect individuals across the globe, with some individuals experiencing more severe disease than others. The relatively high frequency of re-infections and breakthrough infections observed with SARS-CoV-2 highlights the importance of extending our understanding of immunity to COVID-19. Here, we aim to shed light on the importance of antibody titres and epitope utilization in protection from re-infection. Health care workers are highly exposed to SARS-CoV-2 and are therefore also more likely to become re-infected. We utilized quantitative, multi-antigen, multi-epitope SARS-CoV-2 protein microarrays to measure IgG and IgA titres against various domains of the nucleocapsid and spike proteins. Potential re-infections in a large, diverse health care worker cohort (N = 300) during the second wave of the pandemic were identified by assessing the IgG anti-N titres before and after the second wave. We assessed epitope coverage and antibody titres between the ‘single infection’ and ‘re-infection’ groups. Clear differences were observed in the breadth of the anti-N response before the second wave, with the epitope coverage for both IgG (p = 0.019) and IgA (p = 0.015) being significantly increased in those who did not become re-infected compared to those who did. Additionally, the IgG anti-N (p = 0.004) and anti-S titres (p = 0.018) were significantly higher in those not re-infected. These results highlight the importance of the breadth of elicited antibody epitope coverage following natural infection in protection from re-infection and disease in the COVID-19 pandemic. MDPI 2023-02-20 /pmc/articles/PMC9967965/ /pubmed/36851798 http://dx.doi.org/10.3390/v15020584 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Brief Report
Mullins, Michelle O.
Smith, Muneerah
Maboreke, Hazel
Nel, Andrew J. M.
Ntusi, Ntobeko A. B.
Burgers, Wendy A.
Blackburn, Jonathan M.
Epitope Coverage of Anti-SARS-CoV-2 Nucleocapsid IgA and IgG Antibodies Correlates with Protection against Re-Infection by New Variants in Subsequent Waves of the COVID-19 Pandemic
title Epitope Coverage of Anti-SARS-CoV-2 Nucleocapsid IgA and IgG Antibodies Correlates with Protection against Re-Infection by New Variants in Subsequent Waves of the COVID-19 Pandemic
title_full Epitope Coverage of Anti-SARS-CoV-2 Nucleocapsid IgA and IgG Antibodies Correlates with Protection against Re-Infection by New Variants in Subsequent Waves of the COVID-19 Pandemic
title_fullStr Epitope Coverage of Anti-SARS-CoV-2 Nucleocapsid IgA and IgG Antibodies Correlates with Protection against Re-Infection by New Variants in Subsequent Waves of the COVID-19 Pandemic
title_full_unstemmed Epitope Coverage of Anti-SARS-CoV-2 Nucleocapsid IgA and IgG Antibodies Correlates with Protection against Re-Infection by New Variants in Subsequent Waves of the COVID-19 Pandemic
title_short Epitope Coverage of Anti-SARS-CoV-2 Nucleocapsid IgA and IgG Antibodies Correlates with Protection against Re-Infection by New Variants in Subsequent Waves of the COVID-19 Pandemic
title_sort epitope coverage of anti-sars-cov-2 nucleocapsid iga and igg antibodies correlates with protection against re-infection by new variants in subsequent waves of the covid-19 pandemic
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967965/
https://www.ncbi.nlm.nih.gov/pubmed/36851798
http://dx.doi.org/10.3390/v15020584
work_keys_str_mv AT mullinsmichelleo epitopecoverageofantisarscov2nucleocapsidigaandiggantibodiescorrelateswithprotectionagainstreinfectionbynewvariantsinsubsequentwavesofthecovid19pandemic
AT smithmuneerah epitopecoverageofantisarscov2nucleocapsidigaandiggantibodiescorrelateswithprotectionagainstreinfectionbynewvariantsinsubsequentwavesofthecovid19pandemic
AT maborekehazel epitopecoverageofantisarscov2nucleocapsidigaandiggantibodiescorrelateswithprotectionagainstreinfectionbynewvariantsinsubsequentwavesofthecovid19pandemic
AT nelandrewjm epitopecoverageofantisarscov2nucleocapsidigaandiggantibodiescorrelateswithprotectionagainstreinfectionbynewvariantsinsubsequentwavesofthecovid19pandemic
AT ntusintobekoab epitopecoverageofantisarscov2nucleocapsidigaandiggantibodiescorrelateswithprotectionagainstreinfectionbynewvariantsinsubsequentwavesofthecovid19pandemic
AT burgerswendya epitopecoverageofantisarscov2nucleocapsidigaandiggantibodiescorrelateswithprotectionagainstreinfectionbynewvariantsinsubsequentwavesofthecovid19pandemic
AT blackburnjonathanm epitopecoverageofantisarscov2nucleocapsidigaandiggantibodiescorrelateswithprotectionagainstreinfectionbynewvariantsinsubsequentwavesofthecovid19pandemic